Paul K - Search Results

1

DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.

Ratjen F, Paul K, van Koningsbruggen S, Breitenstein S, Rietschel E, Nikolaizik W. Ratjen F, et al. Among authors: paul k. Pediatr Pulmonol. 2005 Jan;39(1):1-4. doi: 10.1002/ppul.20134. Pediatr Pulmonol. 2005. PMID: 15532079 Clinical Trial.

2

Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis.

Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R. Chen CI, et al. J Cyst Fibros. 2004 Mar;3(1):45-50. doi: 10.1016/j.jcf.2003.12.008. J Cyst Fibros. 2004. PMID: 15463886

3

Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease.

Tafel O, Latzin P, Paul K, Winter T, Woischnik M, Griese M. Tafel O, et al. Among authors: paul k. BMC Pulm Med. 2008 Apr 11;8:6. doi: 10.1186/1471-2466-8-6. BMC Pulm Med. 2008. PMID: 18405368 Free PMC article.

4

Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome.

Griese M, Heinrich S, Ratjen F, Kabesch M, Paul K, Ballmann M, Rietschel E, Kappler M. Griese M, et al. Among authors: paul k. PLoS One. 2012;7(12):e51050. doi: 10.1371/journal.pone.0051050. Epub 2012 Dec 7. PLoS One. 2012. PMID: 23236429 Free PMC article.

5

Effects of an exercise program in children with cystic fibrosis: are there differences between females and males?

Gruber W, Orenstein DM, Braumann KM, Paul K, Hüls G. Gruber W, et al. Among authors: paul k. J Pediatr. 2011 Jan;158(1):71-6. doi: 10.1016/j.jpeds.2010.07.033. Epub 2010 Sep 15. J Pediatr. 2011. PMID: 20833400

6

Motor performance is better than normal in preschool children with cystic fibrosis.

Gruber W, Orenstein DM, Paul K, Hüls G, Braumann KM. Gruber W, et al. Among authors: paul k. Pediatr Pulmonol. 2010 Jun;45(6):527-35. doi: 10.1002/ppul.21098. Pediatr Pulmonol. 2010. PMID: 20503276

7

Oxidative changes of bronchoalveolar proteins in cystic fibrosis.

Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Starosta V, et al. Among authors: paul k. Chest. 2006 Feb;129(2):431-437. doi: 10.1378/chest.129.2.431. Chest. 2006. PMID: 16478863

8

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.

Griese M, Essl R, Schmidt R, Ballmann M, Paul K, Rietschel E, Ratjen F; Beat Study Group. Griese M, et al. Among authors: paul k. Respir Res. 2005 Nov 7;6(1):133. doi: 10.1186/1465-9921-6-133. Respir Res. 2005. PMID: 16274485 Free PMC article. Clinical Trial.

9

The 12-min walk test as an assessment criterion for lung transplantation in subjects with cystic fibrosis.

Rüter K, Staab D, Magdorf K, Bisson S, Wahn U, Paul K. Rüter K, et al. Among authors: paul k. J Cyst Fibros. 2003 Mar;2(1):8-13. doi: 10.1016/S1569-1993(02)00145-5. J Cyst Fibros. 2003. PMID: 15463839

10

Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.

Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F; Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Paul K, et al. Am J Respir Crit Care Med. 2004 Mar 15;169(6):719-25. doi: 10.1164/rccm.200307-959OC. Epub 2003 Dec 18. Am J Respir Crit Care Med. 2004. PMID: 14684561 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results